Pregabalin and gabapentin inhibit substance P-induced NF-kappaB activation in neuroblastoma and glioma cells

J Cell Biochem. 2008 Oct 1;105(2):414-23. doi: 10.1002/jcb.21837.

Abstract

Pregabalin and gabapentin are lipophilic amino acid derivatives of gamma-amino butyric acid that show anticonvulsant and analgesic activity against neuropathic pain. In this study, we investigated their actions on substance P-induced NF-kappaB activation in human neuroblastoma and rat glioma cells. Pregabalin and gabapentin decreased substance P-induced NF-kappaB activation in these cells. These drugs also inhibited NF-kappaB activation in rat spinal dorsal root ganglia cells pre-treated in vitro with substance P. These results suggest a previously undefined role of pregabalin and gabapentin in the regulation of inflammation-related intracellular signaling in both neuronal and glial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amines / pharmacology*
  • Animals
  • Cell Line, Tumor
  • Cyclohexanecarboxylic Acids / pharmacology*
  • Gabapentin
  • Ganglia, Spinal / pathology
  • Glioma / metabolism
  • Glioma / pathology*
  • Humans
  • Inflammation / drug therapy
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology*
  • Pregabalin
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Substance P / pharmacology*
  • gamma-Aminobutyric Acid / analogs & derivatives*
  • gamma-Aminobutyric Acid / pharmacology

Substances

  • Amines
  • Cyclohexanecarboxylic Acids
  • NF-kappa B
  • Substance P
  • Pregabalin
  • gamma-Aminobutyric Acid
  • Gabapentin